BioSpace News Archive

Vivos Therapeutics, Inc. announced that it has closed its previously announced private placement offering with a single institutional investor for $8 million in gross proceeds.

Florida Cancer Specialists & Research Institute, LLC has announced the promotion of three members of its Senior Management Team.

SK Inc., together with its life science affiliates including SK biopharmaceuticals and SK pharmteco, will hold a networking event to expand their global partnerships in the U.S., the world’s largest bio and pharmaceutical market.

ORIC Pharmaceuticals, Inc. today provided program updates and announced upcoming key milestones.

MiMedx Group, Inc., a pioneer and leader in placental biologics, provided the following updates about its business.

VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, today announced FDA approval of the newest generation of its tankless inhaled nitric oxide (iNO) delivery system.

Asklepios BioPharmaceutical, Inc. announced today that it has signed a multi-year research collaboration and option agreement with ReCode Therapeutics.

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe, announced that the company has received a biologics license application approval of the ‘SKYZoster™' from the National Pharmaceutical Regulatory Agency (NPRA) in Malaysia.

FlatTech LLC announced its EpiFaith® Syringe for epidural has received an Innovative Technology contract from Vizient, Inc. the nation’s largest member-driven health care performance improvement company.

Diadem SpA, a company developing the first blood-based test for the early prediction of progression to Alzheimer’s disease, announced that its researchers have developed computational methods that enable its AlzoSure® Predict prognostic technology to accurately identify individuals who will rapidly progress to AD within two years’ time.